Advertisement
Canadian Journal of Cardiology

USE OF COMBINATION PREVENTIVE MEDICAL THERAPY IN PATIENTS WITH NON-OBSTRUCTIVE CORONARY ARTERY DISEASE: SECONDARY ANALYSIS OF THE PROMISE TRIAL

      Non-obstructive coronary artery disease (NOCAD) is commonly found on coronary computed tomography angiography (CCTA) in patients undergoing evaluation of symptoms suggestive of obstructive coronary artery disease (OCAD). Patients with NOCAD have an increased risk of cardiovascular events, yet there is no consensus regarding the optimal use of preventive cardiovascular medical therapy. We analyzed data from the PROMISE trial to compare patterns of preventive medical therapy use and continuation after identifying NOCAD, compared with OCAD or normal coronaries, on CCTA.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect